Home » Topics » Neurology/psychiatric, BioWorld Science

Neurology/psychiatric, BioWorld Science
RSS

Atypical antipsychotics from Spanish university

April 12, 1996

Generic fluoxetine available in Canada

April 5, 1996

Genentech files for new indication for alteplase

April 5, 1996

Zeneca selects NMDA antagonist for preclinical study

April 5, 1996

SIBIA , Ciba-Geigy collaborate to develop CNS drugs

April 5, 1996

GV-150526A in development for stroke

April 5, 1996

TR-810 delivers SOD to the nervous system

April 5, 1996

Novel ETA/ETB antagonist reduces brain injury

April 5, 1996

Eisai claims cerebral antiischemic

April 5, 1996

PPI-368 selected for development

April 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...